Cat. No. 1975
Biological ActivityPotent competitive vanilloid TRPV1 (VR1) receptor antagonist (IC50 = 10 nM). Inhibits capsaicin-induced [Ca2+]i increase in rat DRG neurons, and guinea pig bladder and trachea contractions in vitro.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Appendino et al (2003) Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists. Br.J.Pharmacol. 139 1417. PMID: 12922928.
If you know of a relevant citation for this product please let us know.
Keywords: 6-Iodonordihydrocapsaicin, supplier, Potent, competitive, vanilloids, receptors, antagonists, VR1, TRPV, Channels, Transient, Receptor, Potential
Find multiple products by catalog number
New Products in this Area
TRPC1 and TRPC6 blocker; inhibits mechanosensitive ion channelsOptovin
Reversible photoactive TRPA1 activatorEIPA
Inhibits TRPP3-mediated currents; also inhibits the Na+/H+ exchanger (NHE)ML SA1
Activator of TRPML channelsPhenamil
Inhibits TRPP3-mediated currents; also inhibits epithelial Na+ channelsα-Spinasterol
TRPV1 antagonist; displays in vivo activityML 204
Selective TRPC4 blocker
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.